Doctor of Optometry Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Scott Hauswirth

Optometrist, Corneal and Contact Management Bloomington, MN Doctor of Optometry

NPI 1417942665 CMS profile 109197

9801 Dupont Ave S, Suite 200, Bloomington, MN 55431

Open in the dashboard

General payments

$73,278

170 records reported · program years 2019–2024

Research payments

$500

Paid to them · 1 record reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$14,204 paid to institutions, not to them · program year 2022

Through program year 2024, Scott Hauswirth of Bloomington, MN is reported in the CMS Open Payments database as having received $73,278 across 170 general payments and $500 in research payments paid to them. Separately, studies naming them as principal investigator received $14,204 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Optometrist, Corneal and Contact Management profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $199 3
2023 Research $500 1
2022 General $9,838 30
2021 General $16,930 35
2020 General $11,517 21
2019 General $34,795 81

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Hauswirth
  • Optometrist, Corneal and Contact Management median
  • Middle half of Optometrist, Corneal and Contact Management
  • National median

In program year 2025, general payments to Scott Hauswirth were reported at $0. Among 618 Optometrist, Corneal and Contact Management profiles paid that year, the median was $227 and the middle half received between $95 and $604.

Show as a table
Year Scott Hauswirth Optometrist, Corneal and Contact Management median Middle half National median
2019 $34,795 $203 $84–$530 $163
2020 $11,517 $88 $35–$234 $114
2021 $16,930 $143 $54–$353 $132
2022 $9,838 $167 $65–$422 $149
2023 $0 $195 $76–$549 $160
2024 $199 $202 $85–$523 $164
2025 $0 $227 $95–$604 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Kala Pharmaceuticals, Inc. $13,468 23 payments
  2. Dompe US, Inc. $12,900 24 payments
  3. Shire North American Group Inc $12,216 16 payments
  4. Sight Sciences, Inc. $9,000 28 payments
  5. Sun Pharmaceutical Industries Inc. $7,923 14 payments
  6. Oyster Point Pharma, Inc. $5,621 18 payments
  7. TissueTech, Inc. $1,750 2 payments
  8. Quidel Corporation $1,476 7 payments
  9. Allergan Inc. $1,280 13 payments
  10. AbbVie, Inc. $1,200 1 payment
  11. Other $6,444 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $32,055 26 payments
  2. Honoraria $15,990 16 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $14,380 8 payments
  4. Food and Beverage $6,512 105 payments
  5. Travel and Lodging $4,341 15 payments
Products named General payments · program years 2019–2024
  1. EYSUVIS $12,335 17 payments
  2. XIIDRA $12,216 16 payments
  3. TearCare $8,034 23 payments
  4. Cequa $7,628 9 payments
  5. Oxervate Ophthalmic Solution/Drops $5,660 6 payments
  6. TYRVAYA $5,621 18 payments
  7. OXERVATE Solution/ Drops $2,603 6 payments
  8. Oxervate Ophthalmic Solution/Drops $1,812 6 payments
  9. AmnioGuard $1,750 2 payments
  10. Prokera $1,750 2 payments
  11. Other $15,794 77 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Oyster Point Pharma, Inc. $500 1 payment

Records

171 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist, Corneal and Contact Management in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record